Carbon Monoxide and Prokaryotic Energy Metabolism

Area of Science:

• Microbiology
• Biochemistry
• Toxicology

Background:

• Carbon monoxide (CO) has dual roles in biology, being lethal at high concentrations but beneficial at low doses.
• Low-dose CO acts as an endogenous signaling molecule and exhibits antimicrobial properties.
• Developing CO-releasing molecules and prodrugs is an active area of research for antimicrobial applications.

Purpose of the Study:

• To review the molecular mechanisms underlying CO's effects on microbial growth and respiration.
• To explore CO's potential as an antimicrobial agent by targeting prokaryotic energy metabolism.
• To discuss recent findings on CO's impact on terminal oxidases in bacteria.

Main Methods:

• Literature review of existing research on carbon monoxide's biological effects.
• Analysis of the molecular targets of CO in prokaryotic respiratory chains.
• Discussion of recent findings regarding CO's interaction with terminal oxidases.

Main Results:

• High CO levels are toxic due to binding to essential proteins like globins and cytochrome c oxidase.
• Low CO concentrations can inhibit bacterial growth by interfering with energy metabolism.
• Terminal oxidases in bacterial respiratory chains are potential targets for CO's antimicrobial action.

Conclusions:

• CO's ability to disrupt bacterial energy metabolism presents a promising avenue for developing novel antimicrobial strategies.
• Targeting prokaryotic terminal oxidases with CO could lead to new biotechnological applications.
• Further research is needed to fully elucidate the mechanisms and optimize the use of CO as an antimicrobial agent.